Budesonide/glycopyrronium/formoterol MDI (BGF)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Budesonide/glycopyrronium/formoterol MDI (BGF), covering 2025-05-28 to 2025-05-28. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess the Lung Exposure Bioequivalence of Budesonide, Glycopyrronium, and Formoterol Delivered by BGF MDI With Next-Generation Propellant Compared With BGF MDI With HFA Propellant [Phase 1]